Seminars in Pediatric Neurology
Volume 13, Issue 4 , Pages 262-270 , December 2006

Mental Retardation in Children Ages 6 to 16

  • Sarah E. Shea, MD, FRCPC

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Sarah E. Shea, MD, FRCPC, C/0 IWK Health Centre, P.O. Box 9700, Halifax, Nova Scotia, B3K 6R8 Canada.

References 

  1. Diagnostic and Statistical Manual of Mental Disorders IV. (ed 4).. Washington, DC: American Psychiatric Association; 1994;
  2. American Association on Mental Retardation definition of mental retardation. Available at http://www.aamr.org/Policies/faq_mental_retardation.shtml. Accessed July 17, 2006
  3. Luckasson R, Reeve A. Naming, defining, and classifying in mental retardation. Ment Retard. 2001;39:47–52
  4. Symposium: What’s in a name?. Ment Retard. 2002;40:70–75
  5. Devlieger PJ. From handicap to disability: Language use and cultural meaning in the United States. Disabil Rehabil. 1999;21:346–354
  6. Panek P, Smith J. Assessment of terms to describe mental retardation. Res Dev Disabil. 2005;26:565–576
  7. Shevell M, Ashwal S, Donley D, et al. Practice parameter: Evaluation of the child with global developmental delay. Neurology. 2003;60:367–380
  8. Szymanski L, King BH. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. J Am Acad Child Adolesc Psychiatry. 1999;38:5S–31S
  9. Murphy C, Boyle C, Schendel D, et al. Epidemiology of mental retardation in children. Ment Retard Dev Disabil Res Rev. 1998;4:6–13
  10. Online Mendelian Inheritance in Man. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM. Accessed July 17, 2006
  11. Rourke, Byron: Syndrome of Nonverbal Learning Disabilities. New York, NY: The Guildford Press; 1995;
  12. van Karnebeek C, Scheper F, Abeling N, et al. Etiology of mental retardation in children referred to a tertiary care center: A prospective study. Am J Ment Retard. 2005;110:253–267
  13. Moeschler J, Shevell M Committee on Genetics. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics. 2006;117:2304–2313
  14. Brenner D, Elliston C, Hall E, et al. Estimated risks of radiaition-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176:289–296
  15. Nordin V, Gillberg C. Autism spectrum disorders in children with physical or mental disability or both: Clinical and epidemiological aspects I. Dev Med Child Neurol. 1966;38:297–313
  16. Towbin K. Pervasive developmental disorder not otherwise specified. In:  Cohen D,  Volkmar F editor. Handbook of Autism and Pervasive Developmental Disorders (ed 2). New York, NY: John Wiley & Sons; 1997;p. 131
  17. Wing L. Syndromes of autism and atypical development. In:  Cohen D,  Volkmar F editor. Handbook of Autism and Pervasive Developmental Disorders (ed 2). New York: John Wiley & Sons; 1997;p. 161
  18. Sigman M, Dissanayake C, Arbelle S, et al. Cognition and emotion in children and adolescents with autism. In:  Cohen D,  Volkmar F editor. Handbook of Autism and Pervasive Developmental Disorders (ed 2). New York: John Wiley & Sons; 1997;p. 249
  19. Brownell MM, Yogendran MS. Attention-deficit hyperactivity disorder in Manitoba children: Medical diagnosis and psychostimulant treatment rates. Can J Psychol. 2001;46:264–272
  20. Blanchard LT, Gurka MJ, Blackman JA. Emotional, developmental, and behavioral Health of American Children and their families: A report from the 2003 national Survey of Children’s Health. Pediatrics. 2006;117:1202–1212
  21. Hastinings RP, Beck A, Daley D, et al. Symptoms of ADHD and their correlates in children with intellectual disabilities. Res Dev Disabil. 2005;26:456–468
  22. Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation. J Child Adolesc Psychopharmacol. 2003;13:29–40
  23. Pearson DA, Santos CW, Casat CD, et al. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry. 2004;43:677–685
  24. Correia Filho AG, Bodanese R, Silva TL, et al. Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation. J Am Acad Child Adolesc Psychiatry. 2005;44:748–755
  25. Murphy CC, Yeargin-Allsopp M, Decoufle P, et al. The administrative prevalence of mental retardation in 10 year old children in metropolitan Atlanta, 1985 through 1987. Am J Public Health. 1995;85:319–323
  26. Aman MG, Gharabawi GM. Treatment of behavior disorders in mental retardation: Report on transitioning to atypical antipsychotics, with emphasis on risperidone. J Clin Psychol. 2004;65:1197–1208
  27. Snyder R, Turgay A, Aman M, et al. Risperidone Conduct Study Group Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQ’s. J Am Acad Child Adolesc Psychiatry. 2002;41:1026–1036
  28. Ruedrich S, Swales TP, Fossaceca C, et al. Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: A retrospective review. J Intellect Disabil Res. 1999;43:105–111
  29. Kastner T, Finesmith R, Walsh K. Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation. J Clin Psychopharmacol. 1993;13:448–451
  30. Oathamshaw SC, Haddock G. Do people with intellectual disabilities and psychosis have the cognitive skills required to undertake cognitive behavioural therapy?. JARID. 2006;19:35–46
  31. Mindell JA, Emslie G, Blumer J, et al. Pharmacologic management of insomnia in children and adolescents: Consensus statement. Pediatrics. 2006;117:e1223–e1232
  32. Dodge NN, Wilson GA. Melatonin for treatment of sleep disorders in children with developmental disabilities. J Child Neurol. 2001;16:581–584
  33. Phillips L, Appleton RE. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol. 2004;46:771–775
  34. Graves P, Tracy J. Education for children with disabilities: The rationale for inclusion. J Pediatr Child Health. 1998;34:220–225
  35. Zic A, Igric L. Self-assessment of relationships with peers in children with intellectual disability. J Intellect Disabil Res. 2001;45:202–211
  36. Guralnick MJ, Groom JM. The peer relations of mildly delayed and nonhandicapped preschool children in mainstreamed playgroups. Child Dev. 1987;58:1556–1572
  37. Buttimer J, Tierney E. Patterns of leisure participation among adolescents with a mild intellectual disability. J Intellect Disabil. 2005;9:25–42
  38. Ryan PJ, Singh SP, Guillebaud J. Depot medroxyprogesterone and bone mineral density. J Fam Plann Reprod Health Care. 2002;28:12–15
  39. Paransky OI, Zurawin RK. Management of menstrual problems and contraception in adolescents with mental retardation: A medical, legal, and ethical review with new suggested guidelines. J Pediatr Adolesc Gynecol. 2003;16:223–235
  40. National Dissemination Center for Children with Disabilities Connections to Sexuality Education. Available at: http://www.nichcy.org/resources/sexualityeducation.asp. Accessed July 17, 2006
  41. Lumley VA, Miltenberger RG, Long ES, et al. Evaluation of a sexual abuse prevention program for adults with mental retardation. J Appl Behav Anal. 1998;31:91–101
  42. Platt LS. Medical and orthopaedic conditions in special olympics athletes. J Athl Train. 2001;36:74–80
  43. Whalen SS: Effectiveness of occupational therapy in the school environment. CanChild Centre for Disability Research publication. Available at: http://www.canchild.ca/Default.aspx?tabid=121&pid=0. Accessed July 17, 2006
  44. CanChild Centre. Available at: http://www.canchild.ca. Accessed July 17, 2006
  45. Canadian Association for Community Living. Available at: http://www.cacl.ca/english/aboutus/valuesbeliefs.html. Accessed July 17, 2006

PII: S1071-9091(06)00133-1

doi: 10.1016/j.spen.2006.09.010

Seminars in Pediatric Neurology
Volume 13, Issue 4 , Pages 262-270 , December 2006

Article Tools